SCHEMBL4855178

SCHEMBL4855178

COc1cc(COc2nn(C)cc2C=CP(=O)(O)O)ccc1OCc1nc(-c2ccco2)oc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.51
KDM4E B2RXH2 5/20 0.41
HSD17B10 Q99714 4/20 0.41
ALDH1A1 P00352 4/20 0.41
MAPT P10636 4/20 0.41
TSHR P16473 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HPGD P15428 3/20 0.41
TDP1 Q9NUW8 4/20 0.39
ALOX15 P16050 3/20 0.39
LMNA P02545 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
USP2 O75604 2/20 0.36
TP53 P04637 2/20 0.36
MAPK1 P28482 2/20 0.36
PPARA Q07869 1/20 0.36
RECQL P46063 2/20 0.36
POLB P06746 2/20 0.36
MEN1 O00255 1/20 0.36
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4855168 1.00 PPARG (0.51) PPARGKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL4850612 0.93 PPARG (0.47) PPARGKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL4850628 0.93 PPARG (0.47) PPARGKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL4852799 0.93 PPARG (0.48) PPARGKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL4852813 0.93 PPARG (0.48) PPARGKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL4854532 0.90 PPARG (0.47) PPARGKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL4845581 0.90 PPARG (0.47) PPARGKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL4845589 0.90 PPARG (0.47) PPARGKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL4844065 0.90 PPARG (0.55) PPARGKDM4EHSD17B10ALDH1A1MAPT
SCHEMBL4846344 0.89 PPARG (0.52) PPARGKDM4EHSD17B10ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7368578-B2 Five-membered heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-06 US disclosed
US-20060135578-A1 Five-membered heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-06-22 US disclosed
EP-1541564-A1 FIVE-MEMBERED HETEROCYCLIC COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2005-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135578-A1 Five-membered heterocyclic compounds GPR119, OR10J3, CYP11B1 PPARG 536/4885KDM4E 719/4885HSD17B10 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.